Mirum Pharmaceuticals, Inc. MIRM
What the 10-K filed Feb 25, 2026 says off the balance sheet
10-K notesRisks that are not on the face of the balance sheet. Tickdelta picks sentences with specifics and quotes them as filed. New marks a sentence with nothing like it in the 10-K filed Feb 26, 2025.
Big customers
Customers the company names as a large share of revenue or receivables (it must name any worth 10% of revenue).
“As of December 31, 2025 and as of December 31, 2024, the Company did not have any customers that individually accounted for more than 10% of accounts receivable.”
10% in the 10-K filed 2026-02-25, 10% in the one filed 2025-02-26
Read it in the 10-K
Key suppliers
Parts or manufacturing that depend on one or a few suppliers.
New “Department of Health and Human Services (“HHS”) to negotiate the price of certain single-source drugs that have been on the market for at least seven (7) years covered under Medicare as part of the Medicare Drug Price Negotiation Program.”
Read it in the 10-K
“For example, on March 11, 2021, the American Rescue Plan Act of 2021 was signed into law, which eliminated the statutory Medicaid drug rebate cap, previously set at 100% of a drug’s average manufacturer’s price (“AMP”), for single source and innovator multiple source drugs, effective January 1, 2024.”
Read it in the 10-K
“We rely completely on third parties to manufacture and distribute our clinical and commercial drug supplies, including certain sole-source suppliers and manufacturers.”
Read it in the 10-K
New “As our approved medicines are intended to treat rare diseases, we will only require a low-volume of raw materials and APIs, and in some cases with single-source suppliers and manufacturers.”
Read it in the 10-K
Lawsuits and legal claims
Pending cases, settlements and what the company has set aside for them.
New “On December 19, 2025, we, along with Satiogen Pharmaceuticals, Inc. and Shire Human Genetic Therapies, Inc. as co-plaintiffs, filed four complaints against Sandoz Inc.”
Read it in the 10-K
“An estimated loss contingency is accrued in the Company’s consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.”
Read it in the 10-K
New “During the periods presented, the Company has not recorded any accruals for loss contingencies.”
Read it in the 10-K
New “On December 19, 2025, the Company, along with Satiogen Pharmaceuticals, Inc. and Shire Human Genetic Therapies, Inc. as co-plaintiffs, filed four complaints against Sandoz Inc.”
Read it in the 10-K
Guarantees and indemnities
Promises to pay someone else's debts or losses if they cannot.
“Issuance of common stock in connection with settlement of Contingent Milestone and Indemnification Holdback liabilities $ — $ — $ 5,188”
Read it in the 10-K
Debt covenants
Conditions in loan agreements that, if broken, can make debt due early.
No specific sentence about this in the 10-K.
Commitments off the balance sheet
Contracts the company must pay for later: purchase obligations, take-or-pay deals.
No specific sentence about this in the 10-K.
Companies it names
Tracked companies that its latest 10-K or its 8-Ks of the last year call a customer or a supplier.
No other tracked company is named as a customer or a supplier in the latest filings.
Companies that name it
Tracked companies whose latest 10-K or 8-Ks call it a customer or a supplier.
No other tracked company names it as a customer or a supplier in the latest filings.
Sentences are chosen by their words, not read by AI, so some can be off topic. Always check the filing. Open the 10-K
Sources
The notes to the financial statements, Legal Proceedings and the MD&A of the latest 10-K (and, for customers and suppliers, Business and Risk Factors), quoted as filed.
Also
Debt: the debt note in numbers.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MIRM/export.csv") into a cell.